Heparin cofactor II deficiency in the elderly: comparison with antithrombin III.
We investigated heparin cofactor II (HC II) levels and their relationship to other haemostatic factors in the elderly in comparison with antithrombin III (AT III). We measured plasma HC II activity levels in 166 subjects aged from 61 to 99 years using a chromogenic method. HC II levels (94.4 +/- 18.5%) in the healthy elderly subjects were significantly (p less than 0.001) lower than in 40 healthy adult controls under 60 years of age (mean age: 51.5 years; 111.6 +/- 21.2%). HC II levels in the elderly subjects decreased further with age (r = 0.308, p less than 0.001) and the extent of the decrease was more marked than that for AT III (r = 0.179, p less than 0.05). There was no significant sex difference in HC II levels in the elderly. HC II levels correlated significantly with AT III levels and with acute phase reactants including sialic acid, fibrinogen, and PAI-1. HC II levels also correlated with factor VII, plasminogen, alpha 2-plasmin inhibitor, serum lipid, pseudocholinesterase, and albumin levels. These correlations were also found for AT III except active PAI-1 and tPA-PAI-1 complexes, but the correlations with acute phase reactants were stronger for HC II than AT III. We divided 154 elderly subjects into 4 groups by their pseudocholinesterase and albumin levels to estimate the effect of nutritional status on antithrombin activity in the elderly. HC II levels were normal in the elderly subjects with a good nutritional state (103 +/- 18%), but were significantly decreased in those with malnutrition (85 +/- 15%, p less than 0.001). AT III levels also showed the same tendency. These results indicate a decrease in the reserve capacity to inhibit thrombin generation at sites of atherosclerosis in response to trigger events. The deficiency of two major antithrombin factors in the elderly may indicate a tendency to thrombosis, especially in individuals with malnutrition. When considering the clinical significance of HC II, several other parameters, including age, nutritional status, hepatic synthetic ability, and the presence or absence of acute phase reaction should also be assessed.
Kario
K
K
Department of Internal Medicine, Hyogo Prefectural Awaji Hospital, Sumoto, Japan.
Matsuo
T
T
Kobayashi
H
H
D000209:Acute-Phase Proteins / Q000032:analysis; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D000990:Antithrombin III / Q000032:analysis*; D001779:Blood Coagulation Factors / Q000032:analysis; D002091:Butyrylcholinesterase / Q000097:blood; D005260:Female; D015844:Heparin Cofactor II / Q000032:analysis / Q000172:deficiency*; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D019158:N-Acetylneuraminic Acid; D009748:Nutrition Disorders / Q000097:blood; D012794:Sialic Acids / Q000032:analysis
D000209:Acute-Phase Proteins; D001779:Blood Coagulation Factors; D008055:Lipids; D012794:Sialic Acids; D015844:Heparin Cofactor II; D000990:Antithrombin III; D002091:Butyrylcholinesterase; D019158:N-Acetylneuraminic Acid